Piper Jaffray Companies upgraded shares of Henry Schein, Inc. (NASDAQ:HSIC) from a neutral rating to an overweight rating in a research report released on Friday, Marketbeat Ratings reports.

Several other equities research analysts have also commented on the stock. Credit Suisse Group restated a hold rating and issued a $87.50 price target on shares of Henry Schein in a research note on Tuesday, August 29th. Zacks Investment Research lowered shares of Henry Schein from a buy rating to a hold rating in a research note on Wednesday, August 9th. Northcoast Research upgraded shares of Henry Schein from a neutral rating to a buy rating and set a $109.00 price target on the stock in a research note on Monday, August 7th. BidaskClub lowered shares of Henry Schein from a hold rating to a sell rating in a research note on Wednesday, August 2nd. Finally, Jefferies Group LLC restated a hold rating and issued a $88.50 price target on shares of Henry Schein in a research note on Friday, July 21st. One analyst has rated the stock with a sell rating, nine have given a hold rating and seven have assigned a buy rating to the company. The stock has an average rating of Hold and an average target price of $93.30.

Shares of Henry Schein (HSIC) opened at 80.90 on Friday. Henry Schein has a one year low of $73.11 and a one year high of $93.50. The stock has a market cap of $6.40 billion, a price-to-earnings ratio of 11.82 and a beta of 1.10. The firm has a 50-day moving average price of $86.12 and a 200-day moving average price of $88.07.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, August 8th. The company reported $0.88 EPS for the quarter, beating the consensus estimate of $0.86 by $0.02. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The company had revenue of $3.06 billion for the quarter, compared to analyst estimates of $3.05 billion. During the same quarter last year, the business earned $0.82 earnings per share. Henry Schein’s revenue was up 6.4% compared to the same quarter last year. Analysts anticipate that Henry Schein will post $3.64 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Henry Schein, Inc. (HSIC) Upgraded at Piper Jaffray Companies” was first reported by Daily Political and is the property of of Daily Political. If you are reading this piece of content on another domain, it was stolen and reposted in violation of US & international trademark & copyright laws. The correct version of this piece of content can be viewed at https://www.dailypolitical.com/2017/09/19/henry-schein-inc-hsic-upgraded-at-piper-jaffray-companies.html.

In related news, SVP Paul Rose sold 2,126 shares of the firm’s stock in a transaction that occurred on Wednesday, September 6th. The shares were sold at an average price of $172.51, for a total transaction of $366,756.26. Following the completion of the sale, the senior vice president now directly owns 17,841 shares in the company, valued at $3,077,750.91. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 1.27% of the company’s stock.

A number of large investors have recently modified their holdings of the stock. Vanguard Group Inc. boosted its holdings in Henry Schein by 3.0% during the second quarter. Vanguard Group Inc. now owns 8,086,317 shares of the company’s stock worth $1,479,959,000 after buying an additional 236,862 shares in the last quarter. FMR LLC boosted its holdings in Henry Schein by 0.4% during the second quarter. FMR LLC now owns 6,921,367 shares of the company’s stock worth $1,266,749,000 after buying an additional 24,935 shares in the last quarter. BlackRock Inc. boosted its holdings in Henry Schein by 1.8% during the second quarter. BlackRock Inc. now owns 5,696,685 shares of the company’s stock worth $1,042,607,000 after buying an additional 101,406 shares in the last quarter. State Street Corp boosted its holdings in Henry Schein by 1.3% during the first quarter. State Street Corp now owns 3,675,674 shares of the company’s stock worth $624,760,000 after buying an additional 48,469 shares in the last quarter. Finally, Mackenzie Financial Corp boosted its holdings in Henry Schein by 4.7% during the first quarter. Mackenzie Financial Corp now owns 1,728,230 shares of the company’s stock worth $293,747,000 after buying an additional 76,794 shares in the last quarter. Hedge funds and other institutional investors own 89.05% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Analyst Recommendations for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.